Move from the gene label to the therapeutic job
Resources such as Ensembl already represent transcripts, exons and translated protein sequences. BioTwin’s curated assessment uses isoform context to challenge an intervention hypothesis: are the relevant products interchangeable, or could suppressing one have a different consequence from suppressing another?
Put the distinction into the assay
Compare the relevant sequence, expression and functional annotations, then identify the assay that can separate the products in the intended setting. A gene-level readout may be adequate for one question and conceal the distinction that matters for another.
A targeted assessment, with coverage stated
Current work supports curated isoform comparisons. It does not establish exhaustive isoform coverage or measured isoform selectivity. Expression and function in the target tissue are evidence to obtain, rather than properties to infer from a transcript label.
Carry the right protein product into the next calculation
An interface or modification-state analysis could change when its input sequence changes. An RNA-directed strategy raises a related question about transcript specificity. Each requires its own compatible inputs and functional evidence.
- Protein interfaces · Investigate the arrangement for the relevant protein product. Protein interfaces
- Modification context · Consider the sequence and modification state together. Modification context